April 20, 2012 — GE Healthcare and NXT2B, a privately owned venture capital company, announced they have entered into a joint financing agreement with the goal of developing a micro-scale radiotracer infrastructure including cyclotron and positron emission tomography (PET) tracer production. The three-year development project will be led by GE Healthcare and will be headquartered in Uppsala, Sweden. The terms of the agreement were not disclosed.

April 20, 2012 — Guided Therapeutics Inc. announced this week that the LuViva Advanced Cervical Scan is being introduced to medical leaders at the 40th Anniversary Meeting of the British Society for Colposcopy and Cervical Pathology (BSCCP) in Gateshead, United Kingdom, by Eurosurgical Ltd., the company’s U.K. distributor.

Over the past several years, the radiology community has taken it on the chin with reimbursement cuts to reports of radiation overexposure. Earlier this month, it looked like radiology would be hit again, this time by nine physician societies whose leaders compiled a list of “five things physicians and patients should question” – part of a concerted “Choosing Wisely” campaign launched by organized medicine.

April 19, 2012 — GE Healthcare this week announced it has received U.S. Food and Drug Administration (FDA) clearance of Q.Freeze, one of the positron emission tomography/computed tomography (PET/CT) quantitative imaging technologies designed to enable treatment evaluation earlier in a patient’s cancer treatment.

April 19, 2012 — Carestream Healthcare announced it received U.S. Food and Drug Administration (FDA) clearance for its Carestream DRX-Revolution Mobile X-Ray System, and is now accepting orders from U.S. healthcare facilities.

April 19, 2012 - The FDA received a report from a hospital that 16 patients had developed hospital-acquired infections with the bacteria Pseudomonas aeruginosa following an examination with transesophageal echo (TEE) ultrasound probes using Other-Sonic Generic Ultrasound Transmission Gel. Upon investigation, theultrasound gel was found to be contaminated with the bacteria Pseudomonas aeruginosa and Klebsiella oxytoca. Manufactured by Pharmaceutical Innovations Inc., the non-sterile gel is used in ultrasound procedures to improve the transmission of the ultrasound signal from the transducer to the body.

LifeTouch Patient Surveillance System

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now